Ignite Creation Date:
2024-05-06 @ 7:40 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06099990
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-25
First Post:
2023-10-13
Brief Title:
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets I and Prednisone Tablets AA-P Versus Placebo Combined With AA-P in Treatment of High-volume Metastatic Hormone-sensitive Prostate Cancer mHSPC
Sponsor:
Jiangsu HengRui Medicine Co Ltd
Organization:
Jiangsu HengRui Medicine Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-10-13
First Submit QC Date:
October 20 2023
Study First Post Date:
2023-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-20
Last Update Post Date:
2023-10-25
Last Update Post Date Type:
ACTUAL